Meridian Medical Technologies, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Meridian Medical Technologies, Inc. - overview

Established

1968

Location

St. Louis, MO, US

Primary Industry

Healthcare

About

Meridian Medical Technologies, Inc. specializes in developing and manufacturing innovative drug delivery systems and medical devices, providing essential solutions in the healthcare sector. Founded in 1968 and headquartered in St. Louis, US, Meridian Medical Technologies, Inc.


focuses on drug delivery systems and is a subsidiary of Kindeva Drug Delivery L. P. In November 2022, the company merged with Kindeva Drug Delivery L. P.


, which aims to create a drug-device combination product contract development and manufacturing organization. The firm has undergone two funding deals, with the most recent being a BUYOUT of USD 51. 000 mn led by Altaris, reflecting its strategic focus on enhancing operational capabilities and market reach. Meridian Medical Technologies, Inc.


offers a range of medical devices and drug delivery systems designed to improve patient outcomes. The company specializes in developing innovative solutions that facilitate the efficient administration of medications, catering primarily to healthcare providers. Their products are utilized in various medical settings, demonstrating a commitment to advancing medical technology and improving accessibility to crucial healthcare solutions. Meridian Medical Technologies, Inc.


generates revenue through the sale of its drug delivery systems and medical devices, primarily targeting healthcare providers and institutions. The company operates under a business model that includes direct sales and partnerships with other firms in the healthcare sector. Revenue streams are established through contractual agreements and product sales, ensuring a steady flow of income as they fulfill the demands of healthcare markets. Meridian Medical Technologies, Inc.


is focused on expanding its product offerings and market presence through the recent merger with Kindeva Drug Delivery L. P. , which took place in November 2022. This strategic move aims to leverage combined expertise to enhance drug-device product development and contract manufacturing capabilities.


The company plans to explore additional markets and geographical regions to broaden its reach, although specific targets have not been disclosed. The recent USD 51. 000 mn from the BUYOUT will be utilized to support these initiatives, enhancing their operational infrastructure and facilitating new product development.


Current Investors

Kindeva Drug Delivery L.P.

Primary Industry

Healthcare

Sub Industries

Hospitals, Emergency Services, Pharmaceuticals, Defence

Website

www.meridianmeds.com

Company Stage

Merged

Total Amount Raised

Subscriber access only

Meridian Medical Technologies, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
MergerCompletedKindeva Drug Delivery L.P., Meridian Medical Technologies, Inc.-
BuyoutCompletedMeridian Medical Technologies, Inc.-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.